MyAverix Finance
F · Healthcare
Neuren Pharmaceuticals Limited (NK9)
Biotechnology
Neuren Pharmaceuticals Limited (NK9) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-30, reported market cap is $861.15M, P/E ratio is 48.57, net margin is 47.1%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for NK9
Neuren Pharmaceuticals Limited (NK9) — FAQ
What is Neuren Pharmaceuticals Limited's market cap?
Neuren Pharmaceuticals Limited (NK9) has a reported market cap of $861.15M (data as of 2026-03-30).
What is NK9's P/E ratio?
The price-to-earnings (P/E) ratio for Neuren Pharmaceuticals Limited (NK9) is 48.57 (data as of 2026-03-30).
Does Neuren Pharmaceuticals Limited pay a dividend?
Dividend yield is not available in the current snapshot for Neuren Pharmaceuticals Limited (NK9). Check the MyAverix Finance app for the latest dividend data.
What sector is Neuren Pharmaceuticals Limited in?
Neuren Pharmaceuticals Limited (NK9) is classified in the Healthcare sector (Biotechnology industry).
What exchange is NK9 listed on?
NK9 is listed on F.
What is Neuren Pharmaceuticals Limited's net margin?
Neuren Pharmaceuticals Limited (NK9) reports a net margin of 47.1% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.